Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies

Sponsor
Ruihua Wei
Study ID
NCT07186088
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Myopia

Eligibility Criteria

Sex
ALL
Age
18 Years - 35 Years
Healthy Volunteers
Not accepted

Interventions

  • Eyerising RS-200-2A — DEVICE
    Eyerising RS-200-2A,1 time,2 times, 3 times a day
  • Airdoc Sky-n1201 — DEVICE
    Eyerising RS-200-2A,2 times a day

Study Details

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light

Key Dates

First listed
Sep 22, 2025
Start date
Sep 20, 2025
Status verified
Sep 2025
Primary completion
Mar 20, 2026
Completion
Jun 20, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: The Laser Group
    Use Eyerising (RS-200-2A), 1 time,2 times or 3 times a day
  • Experimental: The LED Group
    Use Airdoc (Sky-n1201), 2 times a day

Primary Outcome Measure

Axial length [ Time Frame: From enrollment to the end of treatment up to 7 months ]

Central Contacts

Related Studies